Safety of perioperative intravenous different doses of dexamethasone in primary total joint arthroplasty: a retrospective large-scale cohort study
Abstract Purpose Perioperative intravenous different doses of dexamethasone (DEX) can realize effective clinical outcomes in total joint arthroplasty (TJA). However, the effect of different DEX doses on readmission rates and postoperative complications remains unclear. Methods We retrospectively ana...
Saved in:
Main Authors: | Ping Mou, Xiao-Dan Zhao, Xiu-Mei Tang, Zun-Han Liu, Hao-Yang Wang, Wei-Nan Zeng, Duan Wang, Zong-Ke Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-12-01
|
Series: | BMC Musculoskeletal Disorders |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12891-024-08225-z |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risk factors for infectious complications after total elbow arthroplasty
by: A. A. Boyarov, et al.
Published: (2022-09-01) -
Impact of Benign Prostatic Hyperplasia on Postoperative Complications and Periprosthetic Joint Infections After Total Joint Arthroplasty: A Systematic Review and Meta-Analysis
by: Sina Esmaeili, MD, et al.
Published: (2024-12-01) -
Hospital Financial Burden of Surgical Procedures for Periprosthetic Total Hip Arthroplasty Infection
by: Jesus M. Villa, MD, et al.
Published: (2025-02-01) -
Preoperative dental assessment for the reduction of periprosthetic joint infections in patients undergoing total joint replacement: a systematic review and meta-analysis
by: Zbigniew Putowski, et al.
Published: (2024-11-01) -
Perioperative intravenous dexamethasone did not reduce the severity of persistent postsurgical pain after total knee arthroplasty: a prospective, randomized, double-blind, placebo-controlled trial
by: Nitchanant Kitcharanant, et al.
Published: (2024-12-01)